| DERMATOLOGY | PEER-REVIEW References
25. Ballanger F, Baudry P, N’Guyen JM, Khammari A, Dréno B. Heredity: a pronostic factor for acne. Dermatology 2006; 212(2):145– 9
26. Unna P. The Histopathology of Disease of the Skin. New York: Macmillan and Co., 1896
27. Leyden JJ, McGinley KJ, Mills OH, Kligman AM. Propionibacterium levels in patients with and without acne vulgaris. J Investig Dermatol 1975; 65(4): 382–4
28. Coates P, Vyakrnam S, Eady EA, Jones CE, Cove JH, Cunliffe WJ. Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br J Dermatol 2002; 146: 840–8
29. Eady EA, Cove JH, Holland KT, Cunliffe WJ. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermatol 1989; 121(1): 51–7
30. Leyden JJ, McGinley KJ, Cavalieri S, Webster GF, Mills OH, Kligman AM. Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol 1983; 8(1): 41–5
31. Youn SW, Park ES, Lee DH, Huh CH, Park KC. Does facial sebum excretion really affect the development of acne? Br J Dermatol 2005; 153(5): 919–24
32. Chen W, Tsai S-J, Sheu H-M, Tsai J-C, Zouboulis CC. Testosterone synthesized in cultured human SZ95 sebocytes derives mainly from dehydroepiandrosterone. Exp Dermatol 2010; 19(5): 470–2
33. Thiboutot D, Jabara S, McAllister JM, et al. Human skin is a steroidogenic tissue: Steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1). J Invest Dermatol 2003; 120(6): 905–14
34. Chen W, Yang CC, Liao CY, et al. Expression of sex-determining genes in human sebaceous glands and their possible role in the pathogenesis of acne. Journal of the European Academy of Dermatology & Venereology 2006; 20(7): 846–52
35. Kaymak Y, Adisen E, Ilter N, Bideci A, Gurler D, Celik B. Dietary glycemic index and glucose, insulin, insulin-like growth factor-I, insulin-like growth factor binding protein 3, and leptin levels in patients with acne. J Am Acad Dermatol 2007; 57(5): 819–23
36. Thiboutot D. Acne: hormonal concepts and therapy. Clin Dermatol 2004; 22(5): 419–28
37. Deplewski D, Rosenfield RL. Role of hormones in pilosebaceous unit development. Endocr Rev 2000; 21(4): 363–92
38. Deplewski D, Rosenfield RL. Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation. Endocrinology 1999; 140(9): 4089–94
39. Smith RN, Mann NJ, Braue A, Mäkeläinen H, Varigos GA. The effect of high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial. J Am Acad Dermatol 2007; 57(2): 247–56
40. Deplewski D, Rosenfield RL. Role of hormones in pilosebaceous unit development. Endocr Rev 2000; 21(4): 363-92
41. Hoyt G, Hickey MS, Cordain L. Dissociation of the glycaemic and insulinaemic responses to whole and skimmed milk. Br J Nutr 2005, 93(2):175–177
42. Hoppe C, Mølgaard C, Vaag A, Barkholt V, Michaelsen KF. High intakes of milk, but not meat, increase s-insulin and insulin resistance in 8-year- old boys. Eur J Clin Nutr 2005; 59(3): 393–398
43. Rich-Edwards JW, Ganmaa D, Pollak MN, et al. Milk consumption and the prepubertal somatotropic axis. Nutr J 2007; 6:28
44. Norat T, Dossus L, Rinaldi S, et al. Diet, serum insulin-like growth factor- I and IGF-binding protein-3 in European women. Eur J Clin Nutr 2007; 61(1): 91–98
45. Crowe FL, Key TJ, Allen NE, et al. The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition. Canc Epidemiol Biomarkers Prev 2009, 18:1333–1340
46. Xian CJ, Shoubridge CA, Read LC. Degradation of IGF-I in the adult rat gastrointestinal tract is limited by a specific antiserum or the dietary protein casein. J
Endocrinol 1995;146(2): 215-25
47. Melnik B. Milk consumption. Aggravating factor of acne and promoter of chronic diseases of Western societies. J Ger Soc Dermatol 2009; 7(4): 364-370
48. Blum JW, Baumrucker CR. Insulin-like growth factors (IGFs), IGF binding proteins, and other endocrine factors in milk: Role in the newborn. Exp Med Biol 2008; 606: 397-422
49. Robinson HM. The acne problem. South Med J 1949; 42(12): 1050-1060
50. Melnik BC. Evidence for acne-promoting effects of milk and other insulinotropic dairy products. Nestle Nutr Workshop Ser Pediatr Program 2011; 67:131–145
51. Melnik BC, John SM, Schmitz G. Over-stimulation of insulin/IGF-1 signaling by Western diet may promote diseases of civilization: lessons learnt from Laron syndrome. Nutr Metab (Lond) 2011; 8:41
52. Adebamowo CA, Spiegelman D, Danby FW Frazier AL, Willett WC, Holmes MD. High school dietary dairy intake and teenage acne. J Am Acad Dermatol 2005; 52(2): 207–14
53. Adebamowo CA, Spiegelman D, Berekey CS, et al. Milk consumption and acne in adolescent girls. Dermatol Online J 2006; 12(4):1
54. Danby FW. Acne and milk, the diet myth, and beyond. J Am Acad Dermatol 2005; 52(2): 360–362
55. Adebamowo CA, Spiegelman D, Berkey CS, et al. Milk consumption and acne in teenaged boys. J Am Acad Dermatol 2008, 58(5): 787–793
56. Yalcin AS. Emerging therapeutic potential of whey proteins and peptides. Curr Pharm Des 2006; 12(13): 1637–1643
57. Zimecki M, Kruzel ML. Milk-derived proteins and peptides of potential therapeutic and nutritive value. J Exp Ther Oncol. 2007; 6(2): 89–95
58. Ling JML, Schryvers AB. Perspectives on interactions between lactoferrin and bacteria. Biochem Cell Biol 2006; 84(3): 275–281
59. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002; 21(6): 495–505
60. Gannon MC, Nuttall FQ, Westphal SA, Seaquist ER. The effect of fat and carbohydrate on plasma glucose, insulin, C-peptide and triglycerides in normal male subjects. J Am Coll Nutr 1993; 12(1): 36–41
61. Bhathena SJ, Berlin E, Judd JT. Effects of omega 3 fatty acids and vitamin E on hormones involved in carbohydrate and lipid metabolism in men. Am J Clin Nutr 1991;54(4): 684–688
62. Li Y, Seifert MF, Ney DM, et al. Dietary conjugated linolenic acids alter serum IGF-1 and IGF binding protein concentrations and reduce bone formation in rats fed (n-6) or (n-3) fatty acids. J Bone Miner Res 1999; 14(7):1153–1162
63. Herraiz T. Tetrahydro-carbolines, potential neuroactive alkaloids, in chocolate and cocoa. J Agric Food Chem 2000;48(10): 4900-4
64. Bruinsma K, Taren D. Chocolate: food or drug? J Am Diet Assoc 1999; 99(10): 1249–1256
65. Fulton JE Jr, Pay SR, Fulton JE 3rd. Comedogenicity of current therapeutic products, cosmetics, and ingredients in the rabbit ear. J Am Acad Dermatol 1984; 10(1): 96–105
66. Levy SB. Comedogenicity of cosmetics. J Am Acad Dermatol 1984; 10(6):1072
67. Kligman AM, Mills OH Jr. Acne cosmetica. Arch Dermatol 1972; 106(6): 843–50
68. Fulton JE Jr, Bradley S, Aqundez A, Black T. Non-comedogenic cosmetics. Cutis 1976; 17(2): 344–5, 349–51
69. Hughes H, Brown BW, Lawlis GF, Fulton JEJ. Treatment of acne vulgaris by biofeedback relaxation and cognitive imagery. J Psychosom Res 1983; 27(3): 185–91
70. Poli F, Dreno B, Verschoore M. An epidemiological study of acne in female adults: results of a survey conducted in France. J Eur Acad Dermatol Venereol 2001; 15(6): 541–5
71. Griesemer RD. Emotional triggered disease in a dermatologic practice. Psychiatr Ann 1978; 8: 407–12
72. Grodstein F, Speizer F, Hunter D. A prospective study of incident squamous cell carcinoma of the skin in the Nurses Health Study. J Natl Cancer Inst 1995; 87(14): 1061–6
73. Goldminz D, Bennett R. Cigarette smoking
and flap and full thickness graft necrosis. Arch Dermatol 1991; 127(7): 1012–15
74. Schafer T, Nienhaus A, Vieluf D, Berger J, Ring J. Epidemiology of acne in the general population: the risk of smoking. Br J Dermatol 2001; 145(1): 100–4
75. Model D. Smoker’s face: an underrated clinical sign? Br Med J 1985; 291(6511): 1760–2
76. Misery L. Nicotine effects on skin: are they positive or negative? Exp Dermatol 2004; 13(11): 665–70
77. Capitanio B, Sinagra JL, Ottaviani M, Bordignon V, Amantea A, Picardo M. Acne and smoking. Dermatoendocrinol 2009; 1 (3): 129–135
78. Kalayciyan A, Orawa H, Fimmel S, Perschel FH, Gonza´lez J-B, Fitzner RG, et al. Nicotine and biochanin A, but not cigarette smoke, induce anti-inflammatory effects on keratinocytes and endothelial cells in patients with Behcet’s disease. J Invest Dermatol 2007; 127(1): 81–9
79. Williams C, Layton AM. Persistent acne in women : implications for the patient and for therapy. Am J Clin Dermatol 2006; 7(5): 281–290
80. Savage LJ, Layton AM. Treating acne vulgaris: systemic, local and combination therapy. Expert Rev Clin Pharmacol 2010; 3(4): 563–580
81. Goulden V, Clark SM, Cunliffe WJ. Post-adolescent acne: a review of clinical features. Br J Dermatol 1997; 136: 66–70
82. Lucky AW. A review of infantile and pediatric acne. Dermatology 1998; 196:95–7.
83. Ghodsi SZ, Orawa H, Zouboulis CC. Prevalence, severity, and severity risk factors of acne in high school pupils: a community based study. J Invest Dermatol 2009; 129: 2136–41
84. Holland DB, Jeremy AH. The role of inflammation in the pathogenesis of acne and acne scarring. Semin Cutan Med Surg 2005; 24(2):79–83
85. Dreno B, Bettoli V, Ochsendorf F, Perez-Lopez M, Mobacken H, Degreef H, Layton A. An expert view on the treatmentof acne with systemic antibiotics and ⁄ or oral isotretinoin in thelight of the new European recommendations. Eur J Dermatol 2006; 16(5): 565–571
86. Choi CW, Lee DH, Kim HS et al. The clinical features of late onset acne compared with early onset acne in women. J Eur Acad Dermatol Venereol 2011; 25(4): 454–461
87. Johnson BA, Nunley JR. Use of systemic agents in the treatment of acne vulgaris. Am Fam Physician 2000; 62(8): 1823–1830
88. Smith RN, Braue A, Varigos GA, Mann NJ. The effect of a low glycemic load diet on acne vulgaris and the fatty acid composition of skin surface triglycerides. J Dermatol Sci 2008; 50: 41–52
89. Thomas B, Tan JKL. Adherence optimization in acne management. Skin Ther Lett 2011; 7(2): 1–3
90. Williams C, Layton AM. Persistent acne in women: implications for the patient and for therapy. Am J Clin Dermatol 2006; 7(5): 281–290
91. Yentzer BA, Alikhan A, Teuschler H et al. An exploratory study of adherence to topical benzoyl peroxide in patients with acne vulgaris. J Am Acad Dermatol 2009; 60(5): 879–880
92. Allen HB, Lo Presti PJ. Acne vulgaris aggravated by sunlight. Cutis 1980; 26(3): 254–6
93. Vassileva SG, Mateev G, Parish LC. Antimicrobial photosensitive reactions. Archives of Internal Medicine 1998; 158(18): 1993–2000
94. Layton AM, Cunliffe WJ. Phototoxic eruptions due to doxycycline—a dose-related phenomenon. Clin Exp Dermat 1993; 18(5): 425–427
95. Garner SE, Eady EA, Popescu C, Newton J, Li Wan Po A. Minocycline for acne vulgaris: efficacy and safety (Cochrane Review). Cochrane Library Issue 1, Oxford: Update Software, 2003
96. Mashford ML, Fischer G, Marks R, Quirk C, Rose A, Sinclair RD et al. Therapeutic Guidelines: Dermatology. Melbourne: Therapeutic Guidelines Limited; 1999
97. Sams M, Lynch P. Principles and practice of dermatology (2nd edn). New York: Churchill Livingstone, 1996
98. Brajac I, Bilic-Zulle L, Tkalcic M, Loncarek K,
prime-journal.com | July/August 2014
Gruber F. Acne vulgaris: myths and misconceptions among patients and family physicians. Patient Educ Couns 2004; 54: 21–5
99. Tan JK, Vasey K, Fung KY. Beliefs and perceptions of patients with acne. Am Acad Dermatol 2001; 44(3): 439–45
100. Kalminster LH. Acne, what friends or patients ask about. J Am Med Assoc 1978; 239: 2171–2
101. Anonymous. Washing away at acne. Br Med J 1976; 2 (6040): 834–835
102. Swinyer LJ, Swinyer TA, Britt MR. Topical agents alone in acne. A blind assessment study. J Am Med Assoc 1980; 243(16): 1640–1643
103. Dunlap FE, Baker MD, Plott RT, Verschoore M. Adapalene 0.1% gel has low skin irritation potential even when applied immediately after washing. Br J Dermat 1998; 139 (Suppl 52): 23–25
104. Millikan LE. Pivotal clinical trials of adapalene in the treatment of acne. J Euro Acad Dermat Venereology 2001; 15 (Suppl 3): 19–22
105. De Leo V, Musacchio MC, Morgante G, Piomboni P, Petraglia F. Metformin treatment is effective in obese teenage girls with PCOS. Hum Reprod 2006;21(9):2252–6
106. Ciotta L, Calogero AE, Farina M, De Leo V, La Marca A, Cianci A. Clinical, endocrine and metabolic effects of acarbose, an alpha- glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance. Hum Reprod 2001; 16: 2066–72
107. Marsh K, Brand-Miller J. The optimal diet for women with polycystic ovary syndrome? Br J Nutr 2005; 94: 154–65
108. Falsetti L, Eleftheriou Gl: Hyperinsulinemia in the polycystic ovary syndrome: a clinical endocrine and echographic study in 240 patients. Gynecol Endocrinol 1996; 10: 319–326
109. Nestler JE: Insulin regulation of human ovarian androgens. Hum Re- prod 1997; 12(Suppl 1): 53–62
110. Thierry van Dessel HJ, Lee PD, Faessen G, et al: Elevated serum levels of free insulin like growth factor-I levels in polycystic ovary syndrome. J Clin Endocrinol Metab 1999; 84(9): 3030–3035
111. Franks S. Polycystic ovary syndrome. N Engl J Med 1995;13:853–61
112. Dunaif A, Segal K, Shelley D, Green G, Dorbrjansky A. Profound peripheral insulin resistance, independent of obesity in polycystic ovary syndrome. Diabetes 1989; 38: 1165–74
113. Bourne S, Jacobs A. Observations on acne, seborrhoea, and obesity. BMJ 1956;1(4978): 1268–70
114. Berker B, Emral R, Demirel C, Corapcioglu D, Unlu C, Kose K. Increased insu- lin-like growth factor-I levels in women with polycystic ovary syndrome, and beneficial effects of metformin therapy. Gynecol Endocrinol 2004: 19(3): 125–133
115. Ibanez L, Ong K, Valls C, Marcos M V, Dunger D B, de Zegher F. Metformin treatment to prevent early puberty in girls with precocious pubarche. J Clin Endocrinol Metab 2006: 91(8): 2888–2891
116. Brismar K, Fernqvist-Forbes E, Wahren J, Hall K. Effect of insulin on the hepatic production of insulin-like growth factor binding protein-1 (IGFBP-1), IGFBP- 3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab 1994: 79(3): 872–878
117. Arslanian SA, Lewy V, Danadian K, Saad R: Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocor- ticotropin with reduction of insulinemia/ insulin resistance. J Clin En- docrinol Metab 2002; 87(4): 1555–1559
118. Gollnick HPM, Finlay AY, Shear N. Can we define acne as a chronic disease? If so, how and when? Am J Clin Dermatol 2008; 9(5): 279–284
119. Gollnick HP, Finlay AY, Shear N; Global Alliance to Improve Outcomes in Acne. Can we define acne as a chronic disease? If so, how and when? Am. J. Clin. Dermatol.9(5),279–284 (2008).
120. Layton AM, Henderson K, Cunliffe WJ. A clinical assessment of acne scarring. Clin Exp Dermatol 1994; 4: 303–8
45
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56